The dopamine transporter is a sodium-dependent reuptake carrier that is suspected to play a role in such neurologic and psychiatric disorders as Parkinson’s disease, Tourette’s disease, schizophrenia, and addiction. It is a12-transmembrane domain transporter with the N- and C- terminus regions located within the cytoplasm. This antibody to the dopamine transporter was originally designated DAT/e2 and is now termed anti-DAT-ECD, emphasizing that it recognizes an extracellular domain.
This antibody recognizes the second extracellular loop of the dopamine transporter (DAT-ECD) in rat and human. It was produced in rat by immunization with a GST-DAT-loop fusion protein, then construction of a hybridoma with the murine nonsecreting myeloma cell line Sp2/0. The second extracellular loop, consisting of amino acids 180-218, was used to construct the fusion protein.
Applications include immunocytochemistry, immunohistochemistry, immunoblotting, and targeting.
To view protocol(s) for this and other products please visit: www.ATSbio.com/support/protocols